Purpose: Examine the prevalence of myopia and high myopia, at 6 and 9 months postterm and 2 and 3 years postnatal in preterm children with birth weights Ͻ 1251 g who developed high-risk prethreshold retinopathy of prematurity (ROP) in the neonatal period and participated in the Early Treatment for ROP Study.
refractive state appears in infancy and persists into middle childhood. 3, [7] [8] [9] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The advent of peripheral retinal ablation for treatment of severe (threshold) ROP resulted in preservation of vision and retinal structure in many eyes that would have become blind if untreated. Although some investigators have suggested that this treatment, especially with the use of cryotherapy, increased the severity of myopia, 7,19 -25 other studies have reported no difference in severity of myopia in cryotherapy-treated versus laser-treated eyes with severe ROP. 20, 26 Furthermore, data from the multicenter Cryotherapy for ROP (CRYO-ROP) trial 18 indicated that the apparent increase in myopia severity was due to high myopia in eyes in which treatment prevented retinal detachment. Such eyes were likely to be highly myopic, most likely due to the retinopathy itself.
Results from the Early Treatment of ROP (ETROP) trial published in late 2003 indicated that the structural and functional outcome of eyes with ROP can be improved if retinal ablation is performed at a severity of retinopathy less than classic threshold (i.e., at prethreshold severity that had been determined to be high risk for progressing to poor structural outcome). 27, 28 Initial examination of refractive error at 9 months' corrected age showed no difference in the prevalence of myopia (Ն0.25 diopters [D]) or high myopia (Ն5.00 D) between eyes treated at an earlier stage of ROP (early treated [ET] ) and eyes that were managed conventionally (CM) with treatment at threshold if ROP progressed to that stage. 10 However, long-term refractive error results in this cohort have not yet been reported. The purpose of this article is to examine refractive error development to age 3 years in children who participated in the ETROP study.
Participants and Methods
Participants in the randomized trial of early treatment for ROP were 401 infants with birth weights Ͻ 1251 g who were enrolled at the 26 participating centers in the United States between October 1, 2000 and September 30, 2002 . 28 During the neonatal period, all infants had developed prethreshold ROP in one or both eyes that, based on the risk management for ROP program, 27 put the eyes at high risk (Ն15%) of a poor structural outcome at 3 months postterm. In the 317 infants who developed bilateral high-risk prethreshold ROP, one eye was randomly assigned to treatment within 48 hours (ET), and the fellow eye was observed until regression occurred or until threshold ROP developed and was treated (CM). Of the 84 infants who developed high-risk prethreshold ROP in only one eye, 44 eyes were randomized to ET, whereas 40 were randomized to CM. Study protocols were approved by the review boards of all participating institutions. Informed consent was obtained from parents or guardians of all participants before enrollment in the randomized trial and at entry into the long-term follow-up portion of the study. Details of the study design, including details of standardized eye examinations and definitions of prethreshold and threshold ROP, are available elsewhere. 10, 28, 29 Follow-up eye examinations, including cycloplegic retinoscopy, were conducted by a study-certified ophthalmologist when infants reached 6 and 9 months' corrected age and 2 and 3 years' postnatal age.
In keeping with refractive error categories from previous studies, 4, 8, 10 myopia and high myopia were defined as spherical equivalent (SE) of 0.25 D or more of myopia and 5.00 D or more of myopia, respectively. Logistic regression with random effects was used to investigate the prevalence of myopia. This analysis accounts for the longitudinal aspect of the data. Separate analyses were conducted for the ET and CM eyes.
Results

Early Treated and Conventional Management Eyes Included in Analyses
Results are presented for 283 ET and 272 CM eyes at 6 months, 304 ET and 280 CM eyes at 9 months, 281 ET and 253 CM eyes at 2 years, and 268 ET and 243 CM eyes at 3 years. Data were not included from participants who died before the examination (15 at 6 months, 22 at 9 months, 27 at 2 years, and 28 at 3 years) and participants who did not attend the study examination (20 at 6 months, 7 at 9 months, 35 at 2 years, and 48 at 3 years). Table 1 shows that prevalences of myopia at 6 and 9 months were higher in CM eyes than in ET eyes (6 months, P ϭ 0.009; 9 months, P ϭ 0.01), whereas prevalences of high myopia in ET and CM eyes were similar at both ages (6 months, P ϭ 0.08; 9 months, P ϭ 0.06). At 2 years and 3 years, prevalences of myopia and high myopia were similar in ET and CM eyes (myopia: 2 years, P ϭ 0.53, and 3 years, P ϭ 0.81; high myopia: 2 years, P ϭ 0.12, and 3 years, P ϭ 0.53). For both ET and CM eyes, there was an increase in prevalence of myopia over time, occurring mostly between 6 and 9 months. In contrast, prevalence of high myopia increased at each successive age up to 3 years.
Prevalence of Myopia and High Myopia
Within the group of CM eyes (rightmost 2 columns of Table 1 ), the prevalence of myopia and high myopia was greater at all ages in eyes that reached threshold and underwent peripheral retinal ablation than in eyes in which the ROP regressed without reaching threshold. As in the data from the entire group of CM eyes, there was nearly a 10% increase in prevalence of myopia with advancing age in both subgroups, with the majority of the increase occurring between 6 and 9 months. In addition, the prevalence of high myopia increased with advancing age in both subgroups, though the increase in prevalence of high myopia with age was greater in the subgroup that was treated at threshold than in the subgroup of eyes that regressed without requiring treatment. Figure 1 presents the prevalence of myopia and high myopia, stratified by location (zone 1 vs. zone II) of the acute-phase retinopathy. As shown in Table 2 (available at http://aaojournal. org), some eyes could not be included because they could not be refracted or had undergone operative procedures that would be expected to affect refractive development. At each study age, a higher percentage of eyes with ROP in zone I compared with zone II could not be included in the figure due to lack of refractive error information.
Myopia, High Myopia, and Location of Acute-Phase Retinopathy of Prematurity
As shown in the logistic regression with random effects results presented in Table 3 (available at http://aaojournal.org), both ET and CM eyes showed a small age-related increase in prevalence of myopia (the odds increased 1%-2% with each month of age) and high myopia (the odds increased 3% with each month of age), regardless of zone of acute-phase ROP. Location of acute-phase ROP (zone) had no effect on prevalence of myopia in either ET or CM eyes. However, ET eyes with ROP in zone I were more likely to have high myopia than those ET eyes with ROP in zone II. Figure 2 presents the prevalence of myopia and high myopia, stratified by the presence or absence of plus disease. As shown in Table 2 , except at the 6-month examination, a higher percentage of eyes with plus disease than eyes with no plus disease could not be included in the figure. As shown in the logistic regression with random effects results presented in Table 3 , both ET and CM eyes showed a small age-related increase in prevalence of myopia (the odds increased 1%-2% with each month of age) and high myopia (the odds increased 3% with each month of age), regardless of *Refractive error data unavailable due to retinal detachment (RD), media opacity, pupillary miosis, or other difficulty in refracting (46 eyes at 6 mos, 15 eyes at 9 mos, 12 eyes at 2 yrs, and 13 eyes at 3 yrs) and due to exclusion of eyes that underwent vitrectomy, scleral buckling procedures, iridectomy, glaucoma procedures, or cataract surgery in an additional 1 eye at 6 mos, 17 eyes at 9 mos, 16 eyes at 2 yrs, and 16 eyes at 3 yrs. † Refractive error data unavailable due to RD, media opacity, pupillary miosis, or other difficulty in refracting (50 eyes at 6 mos, 22 eyes at 9 mos, 21 eyes at 2 yrs, and 23 eyes at 3 yrs) and due to exclusion of eyes that underwent vitrectomy, scleral buckling procedures, iridectomy, glaucoma procedures, or cataract surgery in an additional 4 eyes at 6 mos, 27 eyes at 9 mos, 25 eyes at 2 yrs, and 21 eyes at 3 yrs. whether or not acute-phase ROP included plus disease. Presence versus absence of plus disease had no effect on prevalence of high myopia in either ET or CM eyes; for CM eyes, those with a history of plus disease were more likely to have myopia than those without a history of plus disease.
Myopia, High Myopia, and Presence of Plus Disease
Distribution of Refractive Errors
The overall distribution of SE refractive error at each of the 4 test ages is provided in Figure 3 for ET and CM eyes. For both groups of eyes, shapes of the distribution are remarkably similar across 
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age, with the exception of the distribution at 6 months, which shows a lower proportion of myopia Ͼ 8 D, higher prevalence of hyperopia in the plano to ϩ2-D range, and higher prevalence of hyperopia in the ϩ2-to ϩ4-D range than is seen in the distributions at older ages. Figure 4 presents the prevalence of myopia and high myopia at 6 and 9 months and 2 and 3 years of age, stratified by severity of ROP residua. Regardless of treatment group, there is generally an increase, regardless of treatment group assignment, in prevalence of myopia and high myopia from the 6-month examination to the 3-year study visit for eyes with normal-appearing posterior poles. However, for eyes with straightened temporal retinal vessels or macular heterotopia the prevalence of myopia is already high at 6 months and increases little after that. High myopia increased between 6 and 9 months' corrected age and remained stable after that for eyes with straightened vessels. For the small number of eyes with macular heterotopia, fewer ET eyes than CM eyes showed high at each study examination.
Myopia, High Myopia, and Retinal Residua of Retinopathy of Prematurity
Discussion
The results of the ETROP trial indicated that early treatment of eyes with high-risk prethreshold ROP provided improved outcomes for visual function and retinal structure compared with conventional management, in which eyes were treated if they reached threshold severity. 28 One of the worrisome and frequent sequelae of prematurity in eyes, with or without ROP, is the possible development of myopia or high myopia at an early age. [1] [2] [3] [4] [5] [6] [7] [8] [9] [11] [12] [13] 17, 22, 25 Although the ETROP trial included only a subset of prematurely born babies with ROP (those who had high-risk prethreshold ROP in one or both eyes), it is important to know whether early treatment of high-risk prethreshold ROP leads to an increased prevalence of myopia. Davitt et al, in an initial report of refractive error data from the ETROP study population, found no difference in the prevalence of myopia or high myopia during infancy in ET versus CM eyes with high-risk prethreshold ROP. 10 The results of the present study extend this finding of no treatment-related difference in the prevalence of myopia or high myopia through follow-up at age 3 years. The results also confirm that CM eyes in which the ROP progresses to require retinal ablative treatment are more likely to develop myopia and high myopia than those CM eyes in which ROP regressed. As described previously, 10, 18 this difference is likely related to severity of ROP and not treatment status.
The across-age data from the present study (Table 1, Fig 3) show an increase in the prevalence of myopia between 6 and 9 months and little change in the prevalence of myopia between 9 months and 3 years, regardless of the timing of treatment. The increase in prevalence of myopia between 6 and 9 months and the stability of prevalence thereafter are consistent with long-term follow-up data from the large CRYO-ROP natural history study of infants with birth weights of Ͻ1251 g. 4, 8 Thus, though the populations of the Ophthalmology Volume 115, Number 6, June 2008 ETROP and CRYO-ROP studies differ, the results from both studies suggest that infants who are myopic by age 1 year are likely to remain myopic during the preschool years. In contrast to the results of the CRYO-ROP study, 4 ,8 the present results demonstrated an increase in prevalence of high myopia in the ETROP population that continued to the time of the 3-year examination. As shown in Figure 3 , this increase was due primarily to an increase in the prevalence of myopia Ն 8 D between 9 months and 3 years. This increase in myopia prevalence was not observed in the CRYO-ROP study, even in the subgroup of eyes with prethreshold ROP, which would include the high-risk prethreshold eyes randomized in the ETROP study. The reasons for the difference in the time course of development of high myopia between the 2 studies are likely related to the different definitions of moderately severe ROP used in the 2 studies and to the lower mean birth weight and gestational age of children in the ETROP study.
The present study is the first large randomized study to examine the prevalence of myopia and high myopia stratified by more subtle differences in severity of acute-phase ROP-zone I versus zone II location and presence versus absence of plus disease. Surprisingly, the results indicated that prevalence of myopia was no greater for zone I disease than for zone II disease, and the prevalence of high myopia was no greater in eyes with plus disease than in eyes without plus disease (Figs 1, 2 ; Table 3 [available at http://aaojournal. org]). There was also no influence of zone on prevalence of high myopia in CM eyes and no influence of plus disease on prevalence of myopia in ET eyes. However, among ET eyes those with acute-phase ROP in zone I showed a higher prevalence of high myopia than those with acute-phase ROP in zone II, and among CM eyes, those with a history of plus disease showed a higher prevalence of myopia than did those with no history of plus disease. Thus, zone I ROP and presence of plus disease, both indicators of severe acutephase ROP, do have an effect, though a relatively minor one, on refractive error development of the eye.
Several factors may have minimized detection of any differences in the prevalence of myopia and high myopia in eyes with zone I versus zone II disease and in eyes with versus without plus disease. First, any overlap between groups (e.g., zone I vs. zone II, plus vs. no plus) could mask differences in prevalence that might be evident if the analysis had been limited to eyes that were unquestionably in one group or the other. This factor is mitigated by the fact that confirming examinations by independent study-certified ophthalmologists were required for randomization into the study and that study-certified ophthalmologists were carefully and repeatedly trained to identify zone I versus zone II and plus versus no plus findings.
A second factor is that there was a higher percentage of eyes with zone I ROP than eyes with zone II ROP and, also, a higher percentage of eyes with plus disease than eyes without plus disease, in which refractive error data were not available due to the inability of eyes to be refracted or to procedures, such as vitrectomy, that affect normal refractive error development (Table 2 [available at http://aaojournal. org]). Had these eyes been measurable for refractive error, the results might have shown a higher prevalence of myopia and high myopia in eyes with more severe disease (zone I ROP or plus disease) than in eyes with less severe disease (zone II or no plus disease).
A third factor is that eyes included in the ETROP study are a highly selected group of eyes. Eyes were included only if they had prethreshold ROP and were judged to be at high risk for an unfavorable outcome based on the variety of variables included in the Risk Model for Retinopathy of Prematurity 2 risk management program, 27 including birth weight, gestational age, and race of the baby, as well as several characteristics of the retinopathy. Thus, the comparison of outcomes for eyes with zone I versus zone II ROP and for eyes with plus disease versus without plus disease is not based on an unbiased random sample of all eyes with these characteristics.
Previous results from the natural history portion of the CRYO-ROP study 4, 8 and from other studies 13, 30 indicated a substantially higher prevalence of myopia and of high myopia in eyes with macular heterotopia than in eyes in which ROP regressed, leaving a normal-appearing posterior pole. Although the present study included eyes with a range of acute-phase severity of ROP much more limited than that of eyes in the CRYO-ROP study, examination of the relation between retinal residua of ROP and refractive error in the present study also indicated a higher prevalence of myopia and of high myopia in eyes with macular heterotopia than in eyes with normal posterior poles (Fig 4) . The present study also examined prevalence of myopia and high myopia in eyes with an intermediate severity of retinal residuaabnormally straightened temporal retinal vessels. Results indicate that these eyes also show an increased prevalence of myopia and of high myopia at all 4 ages at which examinations were conducted. Thus, among eyes that had acute-phase ROP those that develop retinal residua are more likely than those that do not develop residua to show myopia and high myopia during infancy and the preschool years.
In summary, the results of the present study indicate that approximately 70% of eyes that had high-risk prethreshold ROP during the neonatal period are likely to be myopic during infancy and the early preschool years and that the proportion that have high myopia (Ն5 D) increases between ages 6 months and 3 years. The study showed no evidence that earlier treatment of eyes with high-risk prethreshold ROP influenced refractive error development and only limited evidence of an increased prevalence of myopia or high myopia in eyes with zone I ROP compared with eyes having zone II ROP or in eyes with plus disease compared with eyes having no plus disease. However, prevalence of myopia and of high myopia was higher in eyes with retinal residua of ROP than in eyes with normal-appearing posterior poles. These results emphasize the importance of repeated assessment of refractive error over the first 3 years of life in infants who had high-risk prethreshold ROP. Whether these eyes are at risk for increasing high myopia subsequent to age 3 is not known. However, results of the planned follow-up of ETROP study participants at 4, 5, and 6 years of age will provide long-term data on refractive error development in this population. Age analysis is based on measurements at corrected ages 6 and 9 mos and postnatal ages 2 and 3 yrs. *Examines acute-phase ROP in zone I versus zone II. † Examines Presence versus absence of plus disease.
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